PharmaceuticalCompanies
List your company
CompaniesCDMOsAPIGeographyShortagesPatent cliff
Register entry

Samsung Biologics Co., Ltd.

Request a quoteClaim this profile
Registered sites
2
Drug products
57
Live patents
0
Countries
2
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites

Facilities

2
SiteLocationOperationsFEI
Samsung Biologics Co., Ltd.22032South KoreaAnalytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3010479596
Human Genome Sciences, Inc.Rockville, MDUnited StatesAnalytical testing, Active ingredient (API) manufacture3003782237
Catalogue

Marketed products

57

Showing 57 of 57.

BrandGeneric nameFormCategory
-AdalimumabLIQUIDBULK INGREDIENT
-AdalimumabLIQUIDBULK INGREDIENT
-DurvalumabLIQUIDBULK INGREDIENT
-EmicizumabSOLUTIONDRUG FOR FURTHER PROCESSING
-EmicizumabSOLUTIONDRUG FOR FURTHER PROCESSING
-EmicizumabSOLUTIONDRUG FOR FURTHER PROCESSING
-EmicizumabSOLUTIONDRUG FOR FURTHER PROCESSING
-InfliximabINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-InfliximabLIQUIDBULK INGREDIENT
-IpilimumabLIQUIDBULK INGREDIENT
-NivolumabLIQUIDBULK INGREDIENT
-PerflutrenINJECTION, SUSPENSIONDRUG FOR FURTHER PROCESSING
-RilonaceptLIQUIDBULK INGREDIENT
-RituximabLIQUIDBULK INGREDIENT
-THROMBIN ALFALIQUIDBULK INGREDIENT
-TelavancinINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-adalimumabINJECTIONDRUG FOR FURTHER PROCESSING
-aflibercept-yszyLIQUIDBULK INGREDIENT
-amivantamabLIQUIDBULK INGREDIENT
-bamlanivimabLIQUIDBULK INGREDIENT
-belataceptLIQUIDBULK INGREDIENT
-belimumabLIQUIDBULK INGREDIENT
-belimumabLIQUIDBULK INGREDIENT
-bevacizumabINJECTIONDRUG FOR FURTHER PROCESSING
-bevacizumab-bvzrLIQUIDBULK INGREDIENT
-bimekizumabLIQUIDBULK INGREDIENT
-cosibelimabLIQUIDBULK INGREDIENT
-cosibelimabINJECTIONDRUG FOR FURTHER PROCESSING
-daratumumabLIQUIDBULK INGREDIENT
-denosumabINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-denosumabLIQUIDBULK INGREDIENT
-donanemabLIQUIDBULK INGREDIENT
-eculizumabINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-emicizumabINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-emicizumabINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-etesevimabLIQUIDBULK INGREDIENT
-ibalizumabSOLUTIONDRUG FOR FURTHER PROCESSING
-ibalizumabLIQUIDBULK INGREDIENT
-infliximabINJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONDRUG FOR FURTHER PROCESSING
-infliximabLIQUIDBULK INGREDIENT
-ipilimumabSOLUTIONDRUG FOR FURTHER PROCESSING
-ipilimumabSOLUTIONDRUG FOR FURTHER PROCESSING
-ipilimumabSOLUTIONDRUG FOR FURTHER PROCESSING
-lebrikizumabLIQUIDBULK INGREDIENT
-mepolizumabLIQUIDBULK INGREDIENT
-mirvetuximabLIQUIDBULK INGREDIENT
-nirsevimabLIQUIDBULK INGREDIENT
-rituximabLIQUIDBULK INGREDIENT
-rozanolixizumabLIQUIDBULK INGREDIENT
-sacituzumabLIQUIDBULK INGREDIENT
-sotaterceptLIQUIDBULK INGREDIENT
-tildrakizumabLIQUIDBULK INGREDIENT
-tocilizumabLIQUIDBULK INGREDIENT
-trastuzumabLIQUIDBULK INGREDIENT
-trastuzumabLIQUIDBULK INGREDIENT
-ublituximabSOLUTIONDRUG FOR FURTHER PROCESSING
-ublituximabLIQUIDBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.